BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2410379)

  • 21. Contact dermatitis to antituberculosis drugs.
    Holdiness MR
    Contact Dermatitis; 1986 Nov; 15(5):282-8. PubMed ID: 3545669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modern management of tuberculosis.
    Promisloff RA; Johnston RF
    Compr Ther; 1979 Oct; 5(10):25-37. PubMed ID: 498742
    [No Abstract]   [Full Text] [Related]  

  • 23. Drugs for tuberculosis.
    Br Med J; 1968 Sep; 3(5619):664-7. PubMed ID: 4175142
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk factors for hepatotoxicity induced by antituberculosis drugs.
    Devoto FM; González C; Iannantuono R; Serra HA; González CD; Sáenz C
    Acta Physiol Pharmacol Ther Latinoam; 1997; 47(4):197-202. PubMed ID: 9504179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The interest of addiction to first line anti-TB drugs].
    Aniked S; Bakouh O; Bourkadi JE
    Pan Afr Med J; 2014; 19():207. PubMed ID: 25821550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tuberculostatics-induced systemic lupus erythematosus].
    Layer P; Engelhard M
    Dtsch Med Wochenschr; 1986 Oct; 111(42):1603-5. PubMed ID: 3769804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects of antituberculosis drugs causing changes in treatment.
    Gonzalez Montaner LJ; Dambrosi A; Manassero M; Dambrosi VM
    Tubercle; 1982 Dec; 63(4):291-4. PubMed ID: 6926784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Side effects of tuberculostatics (author's transl)].
    Favez G; Wiser H
    Munch Med Wochenschr; 1973 Sep; 115(39):1685-90. PubMed ID: 4801051
    [No Abstract]   [Full Text] [Related]  

  • 29. [The pseudorheumatism of antitubercular chemotherapy. Contribution to the study of the etiopathogenesis of neurotrophic rheumatism].
    Marche J; Chatard P
    Rev Rhum Mal Osteoartic; 1967; 34(1):16-33. PubMed ID: 4169554
    [No Abstract]   [Full Text] [Related]  

  • 30. Antitubercular drugs (isoniazid, rifampin and pyrazinamide): hepatobiliary reactions.
    Vu D; Macdonald L
    CMAJ; 2001 Oct; 165(7):942-3, 946-7. PubMed ID: 11599338
    [No Abstract]   [Full Text] [Related]  

  • 31. The side effects and interactions of antituberculosis drugs.
    Addington WW
    Chest; 1979 Dec; 76(6 Suppl):782-4. PubMed ID: 510025
    [No Abstract]   [Full Text] [Related]  

  • 32. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
    Lee BH; Koh WJ; Choi MS; Suh GY; Chung MP; Kim H; Kwon OJ
    Chest; 2005 Apr; 127(4):1304-11. PubMed ID: 15821209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retreatment of tuberculosis patients in the city of Porto Alegre, Brazil: outcomes.
    Picon PD; Rizzon CF; Bassanesi SL; Silva LC; Della Giustina Mde L
    J Bras Pneumol; 2011; 37(4):504-11. PubMed ID: 21881741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration.
    Okwera A; Whalen C; Byekwaso F; Vjecha M; Johnson J; Huebner R; Mugerwa R; Ellner J
    Lancet; 1994 Nov; 344(8933):1323-8. PubMed ID: 7526098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug reactions observed during DOTS.
    Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
    J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
    Kaminskaia GO; Karachunskiĭ MA; Kolosovskaia VP
    Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752
    [No Abstract]   [Full Text] [Related]  

  • 37. Antituberculous therapy and acute liver failure.
    McKeon J; Patel AM
    Lancet; 1995 May; 345(8958):1170-1. PubMed ID: 7723556
    [No Abstract]   [Full Text] [Related]  

  • 38. Adverse drug reactions in TB therapy: risks and recommendations.
    Yoshikawa TT; Nagami PH
    Geriatrics; 1982 Jul; 37(7):61-8. PubMed ID: 7084671
    [No Abstract]   [Full Text] [Related]  

  • 39. [Directly observed treatment for tuberculosis in a Buenos Aires City hospital].
    González C; Sáenz C; Herrmann E; Jajati M; Kaplan P; Monzón D
    Medicina (B Aires); 2012; 72(5):371-9. PubMed ID: 23089112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Side effects of antitubercular drugs leading to discontinuation of drug therapy].
    Bergan S; Laake K; Bjartveit K
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):279-82. PubMed ID: 7385151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.